56_CD Boots_NNP Group_NNP PLC_NNP annual_JJ report_NN and_CC accounts_NNS 2005_CD notes_NNS relating_VBG to_TO the_DT financial_JJ statements_NNS 9_CD ._.
Tangible_JJ fixed_JJ assets_NNS 2005_CD 2004_CD Fixtures_NNS ,_, Number_NN of_IN shares_NNS million_CD million_CD Land_NNP and_CC Plant_NNP and_CC fittings_NNS ,_, tools_NNS buildings_NNS machinery_NN and_CC equipment_NN Total_JJ Weighted_JJ average_JJ number_NN of_IN shares_NNS used_VBN in_IN basic_JJ earnings_NNS per_IN share_NN calculation_NN 739.8_CD 780.0_CD Group_NNP m_FW m_FW m_FW m_FW Dilutive_JJ effect_NN of_IN options_NNS 1.1_CD 1.7_CD Cost_NN or_CC valuation_NN Weighted_JJ average_JJ number_NN of_IN shares_NNS used_VBN in_IN diluted_JJ earnings_NNS per_IN share_NN calculation_NN 740.9_CD 781.7_CD At_IN 1st_CD April_NNP 2004_CD 700.2_CD 389.0_CD 1,344.1_CD 2,433.3_CD Currency_NNP adjustments_NNS 0.6_CD 0.6_CD 0.9_CD 2.1_CD The_DT weighted_JJ average_JJ number_NN of_IN shares_NNS used_VBN in_IN basic_JJ earnings_NNS per_IN share_NN calculation_NN excludes_VBZ 10.4_CD m_NN Additions_NNS 7.1_CD 19.0_CD 262.2_CD 288.3_CD 2004_CD 12.6_CD m_NN shares_NNS held_VBN by_IN The_DT Boots_NNP ESOP_NNP Trust_NNP ,_, the_DT QUEST_NNP and_CC unappropriated_JJ shares_NNS held_VBN by_IN Disposals_NNP 6.6_CD 27.0_CD 75.0_CD 108.6_CD Boots_NNP Share_NNP Plan_NNP Trustees_NNPS where_WRB the_DT rights_NNS to_TO dividends_NNS have_VBP been_VBN waived_VBN ._.
Reclassifications_NNS 0.7_CD 103.6_CD 104.3_CD The_DT dilutive_JJ effect_NN relates_VBZ to_TO options_NNS under_IN an_DT employee_NN savings_NNS related_VBN scheme_NN and_CC executive_NN option_NN At_IN 31st_CD March_NNP 2005_CD 700.6_CD 278.0_CD 1,636.5_CD 2,615.1_CD schemes_NNS ._.
Depreciation_NN Basic_JJ and_CC diluted_JJ earnings_NNS per_IN share_NN before_IN exceptional_JJ items_NNS are_VBP disclosed_VBN to_TO reflect_VB the_DT underlying_VBG At_IN 1st_CD April_NNP 2004_CD 63.1_CD 238.5_CD 632.3_CD 933.9_CD performance_NN of_IN the_DT group_NN ._.
Intangible_JJ fixed_JJ assets_NNS Reclassifications_NNS 75.3_CD 75.3_CD Purchased_NNP Product_NNP At_IN 31st_CD March_NNP 2005_CD 68.3_CD 166.8_CD 786.9_CD 1,022.0_CD goodwill_NN rights_NNS acquired_VBD Total_NNP Group_NNP m_FW m_FW m_FW Net_NN book_NN value_NN at_IN 31st_CD March_NNP 2004_CD 637.1_CD 150.5_CD 711.8_CD 1,499.4_CD Cost_NN Net_JJ book_NN value_NN at_IN 31st_CD March_NNP 2005_CD 632.3_CD 111.2_CD 849.6_CD 1,593.1_CD At_IN 1st_CD April_NNP 2004_CD 31.9_CD 287.8_CD 319.7_CD The_DT cost_NN of_IN plant_NN and_CC machinery_NN includes_VBZ 19.3_CD m_NN 2004_CD 21.4_CD m_NN in_IN respect_NN of_IN assets_NNS held_VBN under_IN finance_NN Currency_NN adjustments_NNS 2.0_CD 2.0_CD leases_NNS on_IN which_WDT the_DT accumulated_VBN depreciation_NN at_IN the_DT end_NN of_IN the_DT year_NN was_VBD 10.2_CD m_NN 2004_CD 11.1_CD m_NN and_CC for_IN Additions_NNP 4.5_CD 0.8_CD 5.3_CD which_WDT the_DT depreciation_NN charge_NN for_IN the_DT year_NN was_VBD 2.8_CD m_NN 2004_CD 3.6_CD m._NN Disposals_NNS 3.6_CD 3.6_CD Tangible_JJ fixed_JJ assets_NNS include_VBP payments_NNS on_IN account_NN and_CC assets_NNS in_IN course_NN of_IN construction_NN of_IN 79.5_CD m_NN At_IN 31st_CD March_NNP 2005_CD 36.4_CD 287.0_CD 323.4_CD 2004_CD 121.4_CD m._FW Amortisation_NNP Disposals_NNPS include_VBP assets_NNS with_IN a_DT net_JJ book_NN value_NN of_IN 29.3_CD m_NN associated_VBN with_IN the_DT disposal_NN of_IN businesses_NNS At_IN 1st_CD April_NNP 2004_CD 7.9_CD 30.3_CD 38.2_CD see_VBP note_NN 4_CD ._.
Currency_NNP adjustments_NNS 0.1_CD 0.1_CD Charge_NNP for_IN year_NN 1.5_CD 2.2_CD 3.7_CD Disposals_NNS 3.6_CD 3.6_CD 1_CD Impairments_NNP 1.6_CD 1.6_CD At_IN 31st_CD March_NNP 2005_CD 11.0_CD 29.0_CD 40.0_CD Net_JJ book_NN value_NN at_IN 31st_CD March_NNP 2004_CD 24.0_CD 257.5_CD 281.5_CD Net_JJ book_NN value_NN at_IN 31st_CD March_NNP 2005_CD 25.4_CD 258.0_CD 283.4_CD 1_CD The_DT impairment_NN of_IN goodwill_NN relates_VBZ to_TO the_DT exit_NN from_IN the_DT services_NNS businesses_NNS and_CC has_VBZ been_VBN charged_VBN to_TO Exceptional_NNP Items_NNS ._.
Brands_NNP acquired_VBN by_IN the_DT company_NN or_CC by_IN its_PRP$ subsidiaries_NNS ,_, namely_RB Clearasil_NNP and_CC Dobendan_NNP and_CC its_PRP$ derivatives_NNS are_VBP well_RB known_VBN and_CC well_RB positioned_VBN in_IN their_PRP$ markets_NNS and_CC Boots_NNP Healthcare_NNP International_NNP BHI_NNP plans_VBZ to_TO improve_VB this_DT position_NN from_IN a_DT program_NN of_IN continued_JJ investment_NN ._.
BHI_NNP have_VBP therefore_RB concluded_VBN that_IN these_DT brands_NNS have_VBP an_DT indefinite_JJ useful_JJ economic_JJ life_NN and_CC they_PRP are_VBP not_RB being_VBG amortised_VBN ._.
As_IN a_DT consequence_NN ,_, an_DT annual_JJ impairment_NN review_NN is_VBZ undertaken_VBN ._.
The_DT valuation_NN of_IN these_DT brands_NNS is_VBZ in_IN excess_NN of_IN latest_JJS carrying_VBG value_NN of_IN 248.7_CD m._FW The_DT majority_NN of_IN the_DT other_JJ product_NN rights_NNS are_VBP where_WRB the_DT group_NN has_VBZ a_DT licence_NN to_TO market_NN other_JJ peoples_NNS brands_NNS in_IN specific_JJ countries_NNS ._.
